Member Info for Henners007

Avoid listening to the idle chitter chatter on bulletin boards. Some but not many of the contributors are knowledgable, well informed and willing to share knowledge. They do not get flustered and offer sanguine contributions.

AIM is a lottery where the cards are generally stacked against the "small private investor". However, opportunities do throw themselves up, once in a while to turn in a handsome profit. Back to my earlier point. The value of trades in Synairgen from PI's rarely exceeds £10k in value for a single trade. On 3rd April there was a flurry of late reported trades from 2nd April each valued at well above £10k. If you are an institutional or professional investor and you wish to "confuse" the market about direction of travel for the share price late report your trades (on AIM this can be achieved, quite legally). They are shown as deferred trades or off market trades. Do not believe the Buy/Sell indicators given on LSE, they are quite often incorrect. By looking at the actual time of the trades compared to other trades from the same time on the same day you can deduce whether they are a buy or sell. The purpose of this exercise is to perhaps give you a slight advantage over other less well informed PI's.

"A few posters have also mentioned the value of this company has been dictated by one thing and one thing only...the recent drug to potentially alleviate Covid-19." AdamH7 - please cast that comment out of your mind. It is completely untrue. I would suggest you spend the weekend researching Synairgen. It will prove to be time very well spent and then before the Queen's speech on Sunday evening decide whether you are to add more shares.

I think we will see in the days to come that yesterdays late recorded tsunami of transactions at considerably higher price than today was intended and focussed buying.

Another firm foundation laid ahead of the sale of the business.

It would have been good to see the option price higher, but this looks like another logical formality to the eventual end game. Particularly encouraging to see options being made available to other employees.

I must applaud the more logical posters on this board who for many years have been saying the Directors do not seem to be heavily incentivised to make it happen, and that we would have over 1 billion shares in issue. They were quite correct.

Straight from the Synairgen RNS

"As a result of the expedited approvals to conduct a placebo-controlled Phase II clinical trial in COVID-19, the Company expects the pilot phase to have commenced in the week commencing 23 March 2020........................There will be a further decision made whether to progress to pivotal phase once the pilot phase is complete."

I do not recall this very important point being picked up by others. If the pilot phase is successful and the trial moves on to the pivotal phase, the share price will absolutely leap. If the pivotal phase is also successful another sharp upward movement should be expected.

We will surely not have to wait 6/8 weeks from 23rd March to discover whether the trial is moving from the pilot to pivotal phase.

"COVID-19 studies
Nationally expidited COVID-19 studies open or in setup at Southampton - Clinical Characterisation Protocol for Severe Emerging Infection (ISARIC)

This study is designed for the rapid, coordinated clinical investigation of patients with confirmed novel coronavirus infection. The study has been designed to maximize the likelihood that as much data as possible is collected and shared rapidly in a format that can be easily aggregated, tabulated and analysed across many different settings globally. The study is designed to have some level of flexibility in order to ensure the broadest acceptance."

Note use of the word "rapid" twice and "globally"

Remember Nolostillsell it is 1st April after all.

Do you have a date, time and source for this (ex synairgen)? thanks

Thanks Trek, this kind of info is a much stronger indicative of the share price direction in the hear and now. I do not have L2 or similar and keep an eye out for your kind of posts.

Must be higher than 14p, managed to secure some more at 15.4p. Now that Aaron Banks has backed off (for now), and results (hopefully positive) due any time + announcement for debt reduction all looks set fair. Their recent fund raise was at 16p, so topping up now below that level seems to make good sense.

LitteredFox - they all have reported, last week

Probably better to observe for a good while and get a feel for which posters are alert and aware and which ones are fingers in the air type of people. Its the same for all chat rooms across all shares. Jayhayes, this share is worth its share price today (and has been here before) WITHOUT any Covid19 interest. Think what it could be worth if the trial which is now half way through its original two week trial is successful.

In Auction

Hydrogen is highly unstable https://electrek.co/2019/06/11/hydrogen-station-explodes-toyota-halts-sales-fuel-cell-cars/

Voting against the allotment of additional shares would be financial suicide. If as a shareholder I was not happy with the proposal. I would simply sell my shares now and move on. The shares are so comfortably at a premium above the the placing price (which is very unusual) that if shareholders were successful and the proposal was not carried the share price would immediately fall at least to the placing price (pro rata) and usually even further.

I cannot think of a single reason (financial or moral) why any shareholder would vote against the proposal.

Correct Warrenbe. Why? But some of the wording and detail I do not believe has been disseminated previously. For example "To date, early data from this double-blind, placebo-controlled trial have demonstrated that the antiviral responses in the lung (assessed using sputum biomarkers) are similar to those observed in the asthma trial, where we saw clinical benefit in lung function." The source indicates this statement was made sometime today.

OilorNothing, don't be too hasty on Trek Madone's post. Remember Synairgen have been testing their Interferon Beta in approved Clinical Tests for some time now. Are the two linked? Are there any other hospitals in the UK that have made a similar statement about recovering patients? If not perhaps, just perhaps the two are indeed linked. Moreso because it is the same hospital as where Synairgen practice.

Synairgen are based at Southampton University Hospital. They are (for all intents and purposes) one and the same.

Sharesting, the £1billion market for a COPD resolution (ex Covid19) has been public in the market place for a long time. The Synairgen share price was held back earlier this year by the enforced Woodford sale of >20% of the shares in issue and form no other reason. The product has always had massive potential which it would appear is soon to be realised. The shareprice has been as high as 70p in June 2014 (coincidentally when they were "collaberating" with Astra Zeneca ) previously.

Great find Warrenbe. This could have been a contributory reason why the sp rose significantly from 9th March (among other weil signposted reasons!!)